Price (delayed)
$9.92
Market cap
$65.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.77
Enterprise value
$63.88M
electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions
There are no recent dividends present for ECOR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.